COPD is not only one of the several VTE risk factors.

Eur J Intern Med

Centre Hospitalo-Universitaire de Brest, Université de Bretagne Occidentale, Département de Médecine Interne et Pneumologie, CIC INSERM 1412, Brest, FCRIN INNOVTE EA 3878, France.

Published: February 2021

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejim.2020.12.013DOI Listing

Publication Analysis

Top Keywords

copd vte
4
vte risk
4
risk factors
4
copd
1
risk
1
factors
1

Similar Publications

Pulmonary Emboli Mimicking ST-Elevation Myocardial Infarction Patterns.

Cureus

October 2024

Emergency Medicine, Emergency Physicians of Northwest Ohio (EPNO), Toledo, USA.

A pulmonary embolism (PE) is a serious condition characterized by obstruction of the pulmonary arteries, often presenting with symptoms such as sudden shortness of breath and chest pain. While pulmonary emboli and ST-segment elevation myocardial infarctions (STEMI) are distinct clinical entities, they can present with similar electrocardiogram (ECG) findings, complicating diagnosis and management. This study presents two case reports of patients who exhibited ECG changes resembling STEMI but were ultimately diagnosed with PE via CT angiography (CTA).

View Article and Find Full Text PDF

Aim: Venous thromboembolism (VTE) risk significantly increases in patients with an acute exacerbation of chronic obstructive pulmonary disease (AECOPD), which is characterized by an enhanced inflammatory response. This study aimed to evaluate the predictive value of inflammatory biomarkers for VTE in AECOPD.

Methods: A prospective, multicenter study was conducted to include patients hospitalized for AECOPD.

View Article and Find Full Text PDF

Background: We evaluated the diagnostic value of homocysteine (Hcy) levels combined with the Wells score and established a prediction model for venous thromboembolism (VTE) occurrence in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) based on the Hcy level and the Wells score.

Patients And Methods: Clinical information from 914 patients with AECOPD was retrospectively collected in our hospital from June 2020 to October 2023. Receiver operating characteristic curves were plotted to evaluate the diagnostic ability of Hcy concentrations combined with Wells scores and the prediction ability of the model.

View Article and Find Full Text PDF

Biomarkers of Prothrombotic State and Risk Assessment of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease.

Int J Chron Obstruct Pulmon Dis

October 2024

Department of Respiratory and Critical Medicine, Key Laboratory of Respiratory Disease of Ningbo, The First Affiliated Hospital of Ningbo University, Ningbo, People's Republic of China.

Background: Epidemiologic studies have shown that patients with acute exacerbation of COPD (AECOPD) suffer from morbidity and mortality from venous thromboembolism (VTE) and poor diagnosis. Von Willebrand factor (vWF) and plasminogen activator inhibitor type-1 (PAI-1) are frequently investigated in COPD as crucial parameters for coagulation and fibrinolysis. Nevertheless, the role of vWF and PAI-1 in AECOPD needs further exploration.

View Article and Find Full Text PDF

Concordance between risk scales for venous thromboembolism in patients treated in emergency departments.

Emergencias

June 2024

Departamento de Medicina Interna, Clínica Universidad de Navarra, Madrid, España. CIBER Enfermedades Respiratorias (CIBERES), Madrid, España. Interdisciplinar Teragnosis and Radiosomics (INTRA) Research Group, Universidad de Navarra, España.

Objective: To evaluate agreement between risk-assessment models for venous thromboembolism (VTE) in patients hospitalized for medical conditions and to analyze variables associated with the decision to prescribe pharmacological thromboprophylaxis in hospital emergency departments (EDs). Conclusions.

Methods: Prospective observational multicenter cohort study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!